25 related articles for article (PubMed ID: 37709554)
1. Anticancer effect of superoxide dismutase on canine mammary gland tumour in vitro.
Ko BG; An JH; Lee JH; Kim KB; Kim TH; Park SM; Chae HK; Youn HY
Vet Med Sci; 2024 Jan; 10(1):e1323. PubMed ID: 37997503
[TBL] [Abstract][Full Text] [Related]
2. The role of SET/I2PP2A in canine mammary tumors.
Kake S; Tsuji S; Enjoji S; Hanasaki S; Hayase H; Yabe R; Tanaka Y; Nakagawa T; Liu HP; Chang SC; Usui T; Ohama T; Sato K
Sci Rep; 2017 Jun; 7(1):4279. PubMed ID: 28655918
[TBL] [Abstract][Full Text] [Related]
3. Effect of 2-methoxyestradiol treatment on early- and late-stage breast cancer progression in a mouse model.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cell Biochem Funct; 2023 Oct; 41(7):898-911. PubMed ID: 37649158
[TBL] [Abstract][Full Text] [Related]
4. Three-Dimensional Cultivation a Valuable Tool for Modelling Canine Mammary Gland Tumour Behaviour In Vitro.
Huniadi M; Nosálová N; Almášiová V; Horňáková Ľ; Valenčáková A; Hudáková N; Cizkova D
Cells; 2024 Apr; 13(8):. PubMed ID: 38667310
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties.
Panciera T; Citron A; Di Biagio D; Battilana G; Gandin A; Giulitti S; Forcato M; Bicciato S; Panzetta V; Fusco S; Azzolin L; Totaro A; Dei Tos AP; Fassan M; Vindigni V; Bassetto F; Rosato A; Brusatin G; Cordenonsi M; Piccolo S
Nat Mater; 2020 Jul; 19(7):797-806. PubMed ID: 32066931
[TBL] [Abstract][Full Text] [Related]
6. Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate.
Rodríguez-Bejarano OH; Roa L; Vargas-Hernández G; Botero-Espinosa L; Parra-López C; Patarroyo MA
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189064. PubMed ID: 38158026
[TBL] [Abstract][Full Text] [Related]
7. Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells.
Vigneau AL; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2022 Jun; 20(2):437-448. PubMed ID: 34881506
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
9. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.
Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V
Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554
[TBL] [Abstract][Full Text] [Related]
13. Myoepithelial cells in canine mammary tumours.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J
Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
